| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
248,920,000 |
| Market
Cap: |
21.19(B) |
| Last
Volume: |
1,066,125 |
Avg
Vol: |
1,822,505 |
| 52
Week Range: |
$62.82 - $97.14 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 212 |
| Guru Rank Value : 5.8 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile International Flavors & Fragrances is a creator and manufacturer of food, beverage, health and biosciences, scent and pharma solutions and complementary adjacent products. Co.'s business segments are: Nourish, which comprises food ingredients, flavor compounds, and savory solutions and inclusions; Health and Biosciences, which comprises a portfolio of enzymes, food cultures, probiotics and other ingredients for food, home and personal care, and health and wellness applications; Scent, which creates fragrance compounds, fragrance ingredients and cosmetic ingredients and personal care products; and Pharma Solutions, which produces cellulosics and seaweed-based pharma excipients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
1,972 |
13,231 |
| Total Sell Value |
$0 |
$0 |
$170,282 |
$1,580,339 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
1 |
4 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Strzelecki Angela |
President, Pharma Solutions |
• • – |
2024-04-05 |
4 |
D |
$83.34 |
$29,502 |
D/D |
(354) |
7,808 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2024-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,140 |
8,162 |
|
- |
|
| Herriott Simon |
Pres. Health & Biosci. & Scent |
• • – |
2024-04-05 |
4 |
D |
$83.34 |
$41,170 |
D/D |
(494) |
9,002 |
|
- |
|
| Herriott Simon |
Pres. Health & Biosci. & Scent |
• • – |
2024-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,590 |
9,496 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2024-04-05 |
4 |
D |
$83.34 |
$29,169 |
D/D |
(350) |
5,815 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2024-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
968 |
6,165 |
|
- |
|
| Herriott Simon |
Pres. Health & Biosci. & Scent |
• • – |
2024-04-01 |
4 |
D |
$86.37 |
$39,817 |
D/D |
(461) |
7,906 |
|
- |
|
| Herriott Simon |
Pres. Health & Biosci. & Scent |
• • – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,489 |
8,367 |
|
- |
|
| Herriott Simon |
Pres. Health & Biosci. & Scent |
• • – |
2024-03-01 |
4 |
D |
$75.88 |
$7,892 |
D/D |
(104) |
6,878 |
|
- |
|
| Herriott Simon |
Pres. Health & Biosci. & Scent |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
286 |
6,982 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2024-03-01 |
4 |
D |
$75.88 |
$6,146 |
D/D |
(81) |
5,197 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
195 |
5,278 |
|
- |
|
| Clyburn Frank |
Chief Executive Officer |
• • – |
2024-03-01 |
4 |
D |
$75.88 |
$24,509 |
D/D |
(323) |
1,847 |
|
- |
|
| Clyburn Frank |
Chief Executive Officer |
• • – |
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,324 |
2,170 |
|
- |
|
| Richter Glenn R |
CFO |
• • – |
2024-03-01 |
4 |
D |
$75.88 |
$3,490 |
D/D |
(46) |
17,646 |
|
- |
|
| Richter Glenn R |
CFO |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
99 |
17,692 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2024-03-01 |
4 |
D |
$75.88 |
$3,642 |
D/D |
(48) |
7,022 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
130 |
7,070 |
|
- |
|
| Fyrwald J Erik |
CEOOfficer |
• • – |
2024-02-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,290 |
|
5% |
|
| Fyrwald J Erik |
CEOOfficer |
• • – |
2024-02-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,300 |
|
5% |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2024-01-03 |
4 |
D |
$79.99 |
$38,235 |
D/D |
(478) |
6,940 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,341 |
7,418 |
|
- |
|
| Yildiz Beril |
CAO, SVP & Controller |
• • – |
2023-12-15 |
4 |
A |
$79.62 |
$4,156 |
D/D |
52 |
740 |
|
- |
|
| Finzel Ralf |
EVP, Global Operations Officer |
• • – |
2023-12-01 |
4 |
D |
$76.78 |
$149,184 |
D/D |
(1,943) |
3,444 |
|
- |
|
| Finzel Ralf |
EVP, Global Operations Officer |
• • – |
2023-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,387 |
5,387 |
|
- |
|
1472 Records found
|
|
Page 1 of 59 |
|
|
0.29 (0.34%) 
